Expression and function of phospholipase C in breast carcinoma

Advances in Enzyme Regulation

Volumn 49, Issue 1, 2009, Pages 59-73

  Rebecchi, Mario J ^a   Raghubir, Anna ^a   Scarlata, Suzanne ^a   Hartenstine, Michael J ^b   Brown, Thomas ^b   Stallings, Jonathan D ^b  

^a STONY BROOK UNIVERSITY   (United States)

^b MADIGAN ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISOENZYME; MESSENGER RNA; PHOSPHOLIPASE C DELTA; PLCD1 PROTEIN, HUMAN; PLCD3 PROTEIN, HUMAN; SMALL INTERFERING RNA;

ANIMAL; ARTICLE; BREAST TUMOR; CELL MOTION; ENZYMOLOGY; FEMALE; GENETICS; HUMAN; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHENOTYPE; TUMOR CELL LINE;

ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; FEMALE; HUMANS; ISOENZYMES; PHENOTYPE; PHOSPHOLIPASE C DELTA; RNA, MESSENGER; RNA, SMALL INTERFERING;

EID: 66449087449     PISSN: 00652571     EISSN: None     Source Type: Book Series    
DOI: 10.1016/j.advenzreg.2009.01.009     Document Type: Article

References (63)

1. Ada-Nguema A.S., Xenias H., Hofman J.M., Wiggins C.H., Sheetz M.P., and Keely P.J. The small GTPase R-Ras regulates organization of actin and drives membrane protrusions through the activity of PLCepsilon. J Cell Sci 119 (2006) 1307-1319
2. Bertagnolo V., Benedusi M., Brugnoli F., Lanuti P., Marchisio M., Querzoli P., et al. Phospholipase C-{beta}2 promotes mitosis and migration of human breast cancer derived cells. Carcinogenesis 28 (2007) 1638-1645
3. Bertagnolo V., Benedusi M., Querzoli P., Pedriali M., Magri E., Brugnoli F., et al. PLC-beta2 is highly expressed in breast cancer and is associated with a poor outcome: a study on tissue microarrays. Int J Oncol 28 (2006) 863-872
4. Bunney T.D., Harris R., Gandarillas N.L., Josephs M.B., Roe S.M., Sorli S.C., et al. Structural and mechanistic insights into ras association domains of phospholipase C epsilon. Mol Cell 21 (2006) 495-507
5. Bunney T.D., and Katan M. Phospholipase C epsilon: linking second messengers and small GTPases. Trends Cell Biol 16 (2006) 640-648
6. Chen P., Xie H., Sekar M.C., Gupta K., and Wells A. Epidermal growth factor receptor-mediated cell motility: phospholipase C activity is required, but mitogen-activated protein kinase activity is not sufficient for induced cell movement. J Cell Biol 127 (1994) 847-857
7. Cocco L., Faenza I., Fiume R., Maria Billi A., Gilmour R.S., and Manzoli F.A. Phosphoinositide-specific phospholipase C (PI-PLC) beta1 and nuclear lipid-dependent signaling. Biochim Biophys Acta 1761 (2006) 509-521
8. Condeelis J., and Segall J.E. Intravital imaging of cell movement in tumours. Nat Rev Cancer 3 (2003) 921-930
9. Cross J.C., Nakano H., Natale D.R., Simmons D.G., and Watson E.D. Branching morphogenesis during development of placental villi. Differentiation 74 (2006) 393-401
10. Dittmar T., Husemann A., Schewe Y., Nofer J.R., Niggemann B., Zanker K.S., et al. Induction of cancer cell migration by epidermal growth factor is initiated by specific phosphorylation of tyrosine 1248 of c-erbB-2 receptor via EGFR. Faseb J 16 (2002) 1823-1825
11. Evellin S., Nolte J., Tysack K., vom Dorp F., Thiel M., Weernink P.A., et al. Stimulation of phospholipase C-epsilon by the M3 muscarinic acetylcholine receptor mediated by cyclic AMP and the GTPase Rap2B. J Biol Chem 277 (2002) 16805-16813
12. Feng J.F., Gray C.D., and Im M.J. Alpha 1B-adrenoceptor interacts with multiple sites of transglutaminase II: characteristics of the interaction in binding and activation. Biochemistry 38 (1999) 2224-2232
13. Feng J.F., Rhee S.G., and Im M.J. Evidence that phospholipase delta1 is the effector in the Gh (transglutaminase II)-mediated signaling. J Biol Chem 271 (1996) 16451-16454
14. Frank J., Pignata C., Panteleyev A.A., Prowse D.M., Baden H., Weiner L., et al. Exposing the human nude phenotype. Nature 398 (1999) 473-474
15. Fu L., Qin Y.R., Xie D., Hu L., Kwong D.L., Srivastava G., et al. Characterization of a novel tumor-suppressor gene PLC delta 1 at 3p22 in esophageal squamous cell carcinoma. Cancer Res 67 (2007) 10720-10726
16. Guo Y., Rebecchi M., and Scarlata S. Phospholipase C{beta}2 binds to and inhibits phospholipase C{delta}1. J Biol Chem 280 (2005) 1438-1447
17. Hanahan D., and Weinberg R.A. The hallmarks of cancer. Cell 100 (2000) 57-70
18. Harden T.K., and Sondek J. Regulation of phospholipase C isozymes by ras superfamily GTPases. Annu Rev Pharmacol Toxicol 46 (2006) 355-379
19. Hodson E.A., Ashley C.C., Hughes A.D., and Lymn J.S. Regulation of phospholipase C-delta by GTP-binding proteins-rhoA as an inhibitory modulator. Biochim Biophys Acta 1403 (1998) 97-101
20. Homma M.K., Homma Y., Namba M., and Yuasa Y. Enhanced phosphoinositide metabolism in colorectal carcinoma cells derived from familial adenomatous polyposis patients. J Cell Biochem 55 (1994) 477-485
21. Homma Y., and Emori Y. A dual functional signal mediator showing RhoGAP and phospholipase C-delta stimulating activities. EMBO J 14 (1995) 286-291
22. Hwang J.I., Oh Y.S., Shin K.J., Kim H., Ryu S.H., and Suh P.G. Molecular cloning and characterization of a novel phospholipase C, PLC-eta. Biochem J 389 (2005) 181-186
23. Ichinohe M., Nakamura Y., Sai K., Nakahara M., Yamaguchi H., and Fukami K. Lack of phospholipase C-delta1 induces skin inflammation. Biochem Biophys Res Commun 356 (2007) 912-918
24. Illenberger D., Schwald F., Pimmer D., Binder W., Maier G., Dietrich A., et al. Stimulation of phospholipase C-beta2 by the Rho GTPases Cdc42Hs and Rac1. EMBO J 17 (1998) 6241-6249
25. Illenberger D., Walliser C., Nurnberg B., Diaz Lorente M., and Gierschik P. Specificity and structural requirements of phospholipase C-beta stimulation by Rho GTPases versus G protein beta gamma dimers. J Biol Chem 278 (2003) 3006-3014
26. Jezyk M.R., Snyder J.T., Gershberg S., Worthylake D.K., Harden T.K., and Sondek J. Crystal structure of Rac1 bound to its effector phospholipase C-beta2. Nat Struct Mol Biol 13 (2006) 1135-1140
27. Ji Q.S., Winnier G.E., Niswender K.D., Horstman D., Wisdom R., Magnuson M.A., et al. Essential role of the tyrosine kinase substrate phospholipase C-gamma1 in mammalian growth and development. [see comments]. Proc Natl Acad Sci USA 94 (1997) 2999-3003
28. Kassis J., Moellinger J., Lo H., Greenberg N.M., Kim H.G., and Wells A. A role for phospholipase C-gamma-mediated signaling in tumor cell invasion. Clin Cancer Res 5 (1999) 2251-2260
29. Katterle Y., Brandt B.H., Dowdy S.F., Niggemann B., Zanker K.S., and Dittmar T. Antitumour effects of PLC-gamma1-(SH2)2-TAT fusion proteins on EGFR/c-erbB-2-positive breast cancer cells. Br J Cancer 90 (2004) 230-235
30. Kelley G.G., Reks S.E., and Smrcka A.V. Hormonal regulation of phospholipase Cepsilon through distinct and overlapping pathways involving G12 and Ras family G-proteins. Biochem J 378 (2004) 129-139
31. Kolsch V., Charest P.G., and Firtel R.A. The regulation of cell motility and chemotaxis by phospholipid signaling. J Cell Sci 121 (2008) 551-559
32. Leung D.W., Tompkins C., Brewer J., Ball A., Coon M., Morris V., et al. Phospholipase C delta-4 overexpression upregulates ErbB1/2 expression, Erk signaling pathway, and proliferation in MCF-7 cells. Mol Cancer 3 (2004) 15
33. Liotta L.A., and Kohn E.C. The microenvironment of the tumour-host interface. Nature 411 (2001) 375-379
34. Mhaouty-Kodja S. Ghalpha/tissue transglutaminase 2: an emerging G protein in signal transduction. Biol Cell 96 (2004) 363-367
35. Mouneimne G., DesMarais V., Sidani M., Scemes E., Wang W., Song X., et al. Spatial and temporal control of cofilin activity is required for directional sensing during chemotaxis. Curr Biol 16 (2006) 2193-2205
36. Mouneimne G., Soon L., DesMarais V., Sidani M., Song X., Yip S.C., et al. Phospholipase C and cofilin are required for carcinoma cell directionality in response to EGF stimulation. J Cell Biol 166 (2004) 697-708
37. Nakamura Y., Fukami K., Yu H., Takenaka K., Kataoka Y., Shirakata Y., et al. Phospholipase Cdelta1 is required for skin stem cell lineage commitment. EMBO J 22 (2003) 2981-2991
38. Nakamura Y., Hamada Y., Fujiwara T., Enomoto H., Hiroe T., Tanaka S., et al. Phospholipase C-delta1 and -delta3 are essential in the trophoblast for placental development. Mol Cell Biol 25 (2005) 10979-10988
39. Nakamura Y., Ichinohe M., Hirata M., Matsuura H., Fujiwara T., Igarashi T., et al. Phospholipase C-delta1 is an essential molecule downstream of Foxn1, the gene responsible for the nude mutation, in normal hair development. Faseb J 22 (2008) 841-849
40. Nie L., Wu G., Culley D.E., Scholten J.C., and Zhang W. Integrative analysis of transcriptomic and proteomic data: challenges, solutions and applications. Crit Rev Biotechnol 27 (2007) 63-75
41. Noh D.Y., Kang H.S., Kim Y.C., Youn Y.K., Oh S.K., Choe K.J., et al. Expression of phospholipase C-gamma 1 and its transcriptional regulators in breast cancer tissues. Anticancer Res 18 (1998) 2643-2648
42. Nomoto K., Tomita N., Miyake M., Xhu D.B., LoGerfo P.R., and Weinstein I.B. Expression of phospholipases gamma 1, beta 1, and delta 1 in primary human colon carcinomas and colon carcinoma cell lines. Mol Carcinog 12 (1995) 146-152
43. Ochocka A.M., and Pawelczyk T. Isozymes delta of phosphoinositide-specific phospholipase C and their role in signal transduction in the cell. Acta Biochim Pol 50 (2003) 1097-1110
44. Piccolo E., Innominato P.F., Mariggio M.A., Maffucci T., Iacobelli S., and Falasca M. The mechanism involved in the regulation of phospholipase Cgamma1 activity in cell migration. Oncogene 21 (2002) 6520-6529
45. Piechulek T., Rehlen T., Walliser C., Vatter P., Moepps B., and Gierschik P. Isozyme-specific stimulation of phospholipase C-gamma2 by Rac GTPases. J Biol Chem 280 (2005) 38923-38931
46. Prasanna Murthy S.N., Lomasney J.W., Mak E.C., and Lorand L. Interactions of Gh/transglutaminase with PLC-delta1 and with GTP. Proc Natl Acad Sci USA 96 (1999) 11815-11819
47. Ramaswamy S., Ross K.N., Lander E.S., and Golub T.R. A molecular signature of metastasis in primary solid tumors. Nat Genet 33 (2003) 49-54
48. Rebecchi M.J., and Pentyala S.N. Structure, function, and control of phosphoinositide-specific phospholipase C. Physiol Rev 80 (2000) 1291-1335
49. van Rheenen J., Song X., van Roosmalen W., Cammer M., Chen X., Desmarais V., et al. EGF-induced PIP2 hydrolysis releases and activates cofilin locally in carcinoma cells. J Cell Biol 179 (2007) 1247-1259
50. Schmidt M., Evellin S., Weernink P.A., von Dorp F., Rehmann H., Lomasney J.W., et al. A new phospholipase-C-calcium signalling pathway mediated by cyclic AMP and a Rap GTPase. Nat Cell Biol 3 (2001) 1020-1024
51. Scudiero D.A., Shoemaker R.H., Paull K.D., Monks A., Tierney S., Nofziger T.H., et al. Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res 48 (1988) 4827-4833
52. Sidhu R.S., Clough R.R., and Bhullar R.P. Regulation of phospholipase C-delta1 through direct interactions with the small GTPase Ral and calmodulin. J Biol Chem 280 (2005) 21933-21941
53. Snyder J.T., Singer A.U., Wing M.R., Harden T.K., and Sondek J. The pleckstrin homology domain of phospholipase C-beta2 as an effector site for Rac. J Biol Chem 278 (2003) 21099-21104
54. Song C., Hu C.D., Masago M., Kariyai K., Yamawaki-Kataoka Y., Shibatohge M., et al. Regulation of a novel human phospholipase C, PLCepsilon, through membrane targeting by Ras. J Biol Chem 276 (2001) 2752-2757
55. Song C., Satoh T., Edamatsu H., Wu D., Tadano M., Gao X., et al. Differential roles of Ras and Rap1 in growth factor-dependent activation of phospholipase C epsilon. Oncogene 21 (2002) 8105-8113
56. Stallings J., Zhang Y., Naravez F., and Rebecchi M.J. Phospholipase C-δ1 is linked to proliferation, DNA synthesis and cyclin E expression. J Biol Chem 283 (2008) 13992-14001
57. Stallings J.D., Tall E.G., Pentyala S., and Rebecchi M.J. Nuclear translocation of phospholipase C-delta1 is linked to the cell cycle and nuclear phosphatidylinositol 4,5-bisphosphate. J Biol Chem 280 (2005) 22060-22069
58. Suh P.G., Park J.I., Manzoli L., Cocco L., Peak J.C., Katan M., et al. Multiple roles of phosphoinositide-specific phospholipase C isozymes. BMB Rep 41 (2008) 415-434
59. Vargo-Gogola T., and Rosen J.M. Modelling breast cancer: one size does not fit all. Nat Rev Cancer 7 (2007) 659-672
60. Wang W., Eddy R., and Condeelis J. The cofilin pathway in breast cancer invasion and metastasis. Nat Rev Cancer 7 (2007) 429-440
61. Wang W., Mouneimne G., Sidani M., Wyckoff J., Chen X., Makris A., et al. The activity status of cofilin is directly related to invasion, intravasation, and metastasis of mammary tumors. J Cell Biol 173 (2006) 395-404
62. Weber G. Down-regulation of increased signal transduction capacity in human cancer cells. Adv Enzyme Regul 45 (2005) 37-51
63. Yoshimi N., Wang A., Makita H., Suzui M., Mori H., Okano Y., et al. Reduced expression of phospholipase C-delta, a signal-transducing enzyme, in rat colon neoplasms induced by methylazoxymethanol acetate. Mol Carcinog 11 (1994) 192-196